Literature DB >> 12832444

Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines.

Katharina Tschoep1, Thomas C Manning, Helena Harlin, Christopher George, Melissa Johnson, Thomas F Gajewski.   

Abstract

Although antigen-loaded dendritic cells (DC) are being investigated as antitumor vaccines, which DC differentiation state is most effective is not clear. Three DC functions that may be critical for immunization potential are expression of CD80/86, cytokine production following CD40 engagement, and migration to chemokine receptor 7-binding chemokines. We therefore examined highly purified human monocyte-derived immature and mature DC for these properties from normal donors and cancer patients. Although high expression of CD80/86 and migration to 6Ckine + macrophage-inflammatory protein-3beta were properties of mature DC, cytokine production following CD40 ligation was superior by immature DC. Loss of cytokine secretion occurred with multiple maturation conditions, was not apparently reversible, and was also seen with lipopolysaccharide stimulation in correlation with down-regulated Toll-like receptor expression. Our results suggest that the functions thought to contribute to optimal T cell priming are not coexpressed by the same DC population and that immature and mature DC likely possess distinct CD40-mediated signaling events.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832444     DOI: 10.1189/jlb.0702352

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  Accumulation of functionally immature myeloid dendritic cells in lymph nodes of rhesus macaques with acute pathogenic simian immunodeficiency virus infection.

Authors:  Viskam Wijewardana; Anthea L Bouwer; Kevin N Brown; Xiangdong Liu; Simon M Barratt-Boyes
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

Review 2.  T-cell-independent antitumor effects of CD40 ligation.

Authors:  Alexander L Rakhmilevich; Kory L Alderson; Paul M Sondel
Journal:  Int Rev Immunol       Date:  2012-08       Impact factor: 5.311

Review 3.  Dendritic cell vaccines for brain tumors.

Authors:  Won Kim; Linda M Liau
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

4.  Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.

Authors:  Mervat El Ansary; Sherif Mogawer; Samah Abd Elhamid; Sahr Alwakil; Fatma Aboelkasem; Hatem El Sabaawy; Olfat Abdelhalim
Journal:  J Cancer Res Clin Oncol       Date:  2012-08-12       Impact factor: 4.553

5.  Alcohol exposure impairs myeloid dendritic cell function in rhesus macaques.

Authors:  Robert W Siggins; Gregory J Bagby; Patricia Molina; Jason Dufour; Steve Nelson; Ping Zhang
Journal:  Alcohol Clin Exp Res       Date:  2009-05-26       Impact factor: 3.455

6.  Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses.

Authors:  Cheryl Lai-Lai Chiang; Andrea R Hagemann; Rachel Leskowitz; Rosemarie Mick; Thomas Garrabrant; Brian J Czerniecki; Lana E Kandalaft; Daniel J Powell; George Coukos
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.